ADAM GOMOLL: Open Payments
NPI 1598730715 · EAST LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,139 in 127 payments from 20 companies in 2025. Trend: 2023 $1,089 · 2024 $1,692 · 2025 $2,139
Food & beverage: $2,044Education: $95
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 36 | $425 |
| GENZYME CORPORATION | 9 | $235 |
| UCB, Inc. | 8 | $209 |
| Amgen Inc. | 16 | $198 |
| Organon LLC | 17 | $190 |
| ABBVIE INC. | 11 | $178 |
| Arcutis Biotherapeutics, Inc. | 4 | $171 |
| Regeneron Healthcare Solutions, Inc. | 6 | $137 |
| Novartis Pharmaceuticals Corporation | 4 | $74 |
| Galderma Laboratories, L.P. | 3 | $69 |
Products named: TREMFYA, DUPIXENT, Bimzelx, OTEZLA, Zoryve, VTAMA, RINVOQ, LIBTAYO.
Industry payments across MI — which companies pay providers there.
